Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals patterns of GLP-1 receptor agonist prescriptions in adults with severe mental illness, highlighting disparities in metabolic care access.
This cross-sectional study examines glucagon-like peptide-1 (GLP-1) prescriptions among adults with vs without severe mental illness from 2018 to 2024 using national insurance claims.
No takes yet. Share an insight, caveat, or question.
McGinty et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: